Company page

Exelixis, Inc.

Exelixis, Inc. is a publicly traded biotechnology company based in the United States, focused on developing and commercializing innovative therapies for cancer treatment. The company is listed under the ticker EXEL and has a market capitalization of approximately $14.06 billion. Exelixis aims to improve the lives of patients through its advanced research and development efforts in oncology.